Skip to Main Content

LABD  Direxion Daily S&P Biotech Bear 3X…
Exchange-Traded Fund
NYSE Arca

Morningstar Summary

Ratings & Reports

  • Overall
    as of --
    Star Rating: 0Not Rated
    Out of -- funds
  • 3 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 5 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 10 Year
    Star Rating: 0Not Rated
    Out of -- funds

Historical Risk

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Historical Return

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Morningstar Style Box

Market Cap vs. Investment Style
Selected Values: Undefined
Value
Blend
Growth
Large
Mid
Small

Price Movement of LABD

Chart for Price Movement
LABD is down -2.24% over the last 3 days.
Bid/Ask1$3.81 / $4.00
Open$0.00
Previous Close$3.93
Day Low/High
Last Price
$3.93  0% or $32,771.93 from its Day low
--
--
52 Week Range
Last Price
$3.93  1% or $0.16 from its 52 Week low
$3.77
1/16/2018
$16.48
1/24/2017
Price/Earnings--
Price/Cash Flow--
Price/Revenue--

Fund Detail

as of 12/31/2017

Profile

Profile
Total Net Assets$85.2 M
Premium/Discount0.26%
Portfolio Turnover0.00%
Total Holdings11
Fund TypeETF
Transaction FeeYes

Distributions and Yield

Distributions and Yield
Distribution Yield0.00%
Most Recent Dividend--
Previous Pay Date--
Ex-Date--
Distribution FrequencyQuarterly
SEC Yield--

Total Returns

as of 12/31/2017

Standardized Returns

Standardized Returns: Monthly
Description3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception
LABD Market Price
-16.74%-73.23%-------58.49%0.22%-75.67%-------56.77%0.22%-75.67%-------56.77%
LABD NAV
-17.12%-73.30%-------58.49%0.43%-75.63%-------56.55%0.43%-75.63%-------56.55%
Trading--Inverse Equity
Morningstar Category
------------0.26%-24.20%-16.81%-30.49%-20.82%--0.85%-14.46%-21.11%-29.79%-20.40%--
S&P 500
Index
9.78%25.63%13.85%15.89%10.11%10.83%6.64%21.83%11.41%15.79%8.50%10.73%6.64%21.83%11.41%15.79%8.50%10.73%
View Performance >

Top 5 Holdings

as of 12/31/2017
Top 5 Holdings
--S&P Biotechnology Select Industry USD5.87%
--S&P BIOTECHNOLOGY SELECT4.16%
--S&P Biotechnology Select1.58%
Total
11.60%
More Holdings >

Top Sectors

as of 12/31/2017
Top SectorsTop Sectors
Sector% of Holdings
Basic Materials0.00%
Communication Services0.00%
Consumer Cyclical0.00%
Consumer Defensive0.00%
Total0.00%
Fund Highlights
Fund Strategy
The investment seeks daily investment results- before fees and expenses- of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund- under normal circumstances- invests in swap agreements- futures contracts- short positions or other financial instruments that- in combination- provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Morningstar Category
These funds seek to generate returns equal to an inverse fixed multiple of short-term returns of an equity index. The compounding of short-term returns results in performance that does not correspond to those of investing in the index with external leverage. For example, a fund attempting to achieve negative 2 times the returns of a given index on a daily basis is unlikely to deliver anything like negative 2 times the index's returns over periods longer than one day. Many of these funds seek to generate a multiple typically negative 1 to negative 3 times the daily or weekly return of the reference index. Trading funds are not considered suitable for a long-term investor and are designed to be used by active traders.
  • Inception Date
    05/28/2015
  • 1.08%
    Net Expense may include reimbursements or fee waivers, which may be voluntary or contractual and may expire. See prospectus for more details.
  • Gross Expense Ratio
    1.15%
  • Index Fund
    Yes
  • Leveraged Fund
    Yes
  • Socially Conscious
    No
  • Actively Managed
    No
  • Fund Family
Opens a modal dialogOpens a modal dialogOpen flyout contentOpens a new window